Sibannac, Inc. (SNNC)
OTCMKTS · Delayed Price · Currency is USD
0.0119
+0.0014 (13.83%)
Jan 20, 2026, 4:00 PM EST
Sibannac Market Cap
Sibannac has a market cap or net worth of $1.61 million as of January 21, 2026. Its market cap has increased by 22.09% in one year.
Market Cap
1.61M
Enterprise Value
n/a
Revenue
434.00
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since May 19, 2020, Sibannac's market cap has increased from 1.45M to 1.61M, an increase of 10.68%. That is a compound annual growth rate of 1.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 1.61M | -4.59% |
| Dec 31, 2025 | 1.68M | -39.54% |
| Dec 31, 2024 | 2.78M | 70.46% |
| Dec 29, 2023 | 1.63M | 161.36% |
| Dec 30, 2022 | 625.11K | -74.72% |
| Dec 31, 2021 | 2.47M | 128.86% |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
| May 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 723.02M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |